Reports
Reports
The global acute kidney injury treatment market attained a value of USD 41.65 billion in 2022. The industry is further expected to grow at a CAGR of 6.20% in the forecast period of 2023-2028 to reach USD 59.78 billion by 2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increased geriatric population and the growing incidences of acute kidney injury are expected to fuel the growth of the acute kidney injury treatment industry globally. North America is projected to be a leading region in the global acute kidney injury treatment industry due to the increased adoption of advanced technologies in the region.
The global acute kidney injury treatment industry can be broadly categorised based on segments like types, treatments, end-uses, and regions:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The EMR report looks into the regional markets of acute kidney injury treatment like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing number of dialysis centres is projected to drive the dialysis segment, among other treatment-types, in the acute kidney injury treatment industry. Owing to the strong ongoing clinical pipeline, and the advancements in technology, further supporting more efficient products, the market in North America is anticipated to witness a significant growth in the acute kidney injury treatment industry. Government research and development programmes and initiatives in the healthcare sector are further expected to expand the acute kidney injury treatment industry in the Asia Pacific.
The report presents a detailed analysis of the following key players in the global acute kidney injury treatment industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Treatment, End Use, Region |
Breakup by Type | Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Postrenal Acute Kidney Injury, Others |
Breakup by Treatment | Dialysis, Supportive Care |
Breakup by End Use | Hospitals, Ambulatory Surgical Centres, Others |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Angion, AM-Pharma B.V., Baxter International, Inc., Fresenius Medical Care Holdings, Inc., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Acute Kidney Injury Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Acute Kidney Injury Treatment Historical Market (2018-2022)
8.3 Global Acute Kidney Injury Treatment Market Forecast (2023-2028)
8.4 Global Acute Kidney Injury Treatment Market by Type
8.4.1 Prerenal Acute Kidney Injury
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Intrinsic Renal Acute Kidney Injury
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Postrenal Acute Kidney Injury
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Others
8.5 Global Acute Kidney Injury Treatment Market by Treatment
8.5.1 Dialysis
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Supportive Care
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.6 Global Acute Kidney Injury Treatment Market by End User
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Ambulatory Surgical Centres
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Others
8.7 Global Acute Kidney Injury Treatment Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Acute Kidney Injury Treatment Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Acute Kidney Injury Treatment Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Acute Kidney Injury Treatment Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Acute Kidney Injury Treatment Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Acute Kidney Injury Treatment Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Angion
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 AM-Pharma B.V.
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Baxter International, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Fresenius Medical Care Holdings, Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Asahi Kasei Medical Co., Ltd.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 B. Braun Melsungen AG
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Acute Kidney Injury Treatment Market: Key Industry Highlights, 2018 and 2028
2. Global Acute Kidney Injury Treatment Historical Market: Breakup by Type (USD Billion), 2018-2022
3. Global Acute Kidney Injury Treatment Market Forecast: Breakup by Type (USD Billion), 2023-2028
4. Global Acute Kidney Injury Treatment Historical Market: Breakup by Treatment (USD Billion), 2018-2022
5. Global Acute Kidney Injury Treatment Market Forecast: Breakup by Treatment (USD Billion), 2023-2028
6. Global Acute Kidney Injury Treatment Historical Market: Breakup by End User (USD Billion), 2018-2022
7. Global Acute Kidney Injury Treatment Market Forecast: Breakup by End User (USD Billion), 2023-2028
8. Global Acute Kidney Injury Treatment Historical Market: Breakup by Region (USD Billion), 2018-2022
9. Global Acute Kidney Injury Treatment Market Forecast: Breakup by Region (USD Billion), 2023-2028
10. North America Acute Kidney Injury Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
11. North America Acute Kidney Injury Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Europe Acute Kidney Injury Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Europe Acute Kidney Injury Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Asia Pacific Acute Kidney Injury Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Asia Pacific Acute Kidney Injury Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Latin America Acute Kidney Injury Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Latin America Acute Kidney Injury Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Middle East and Africa Acute Kidney Injury Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Middle East and Africa Acute Kidney Injury Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Global Acute Kidney Injury Treatment Market Structure
In 2022, the global acute kidney injury treatment market attained a value of nearly USD 41.65 billion.
The market is projected to grow at a CAGR of 6.20% between 2022 and 2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach about USD 59.78 billion by 2028.
The major drivers of the industry, such as the growing prevalence of acute kidney injury, rising demand for improved healthcare facility, favourable government initiatives, growing geriatric population, and rapid technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the launch of advanced medical devices and growing research and development activities.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America leading the market.
Prerenal acute kidney injury, intrinsic renal acute kidney injury, and postrenal acute kidney injury, among others, are the major types in the industry.
The major treatment segments in the market are dialysis and supportive care.
The significant end use sectors in the industry include hospitals and ambulatory surgical centres, among others.
The major players in the industry are Angion, AM-Pharma B.V., Baxter International, Inc., Fresenius Medical Care Holdings, Inc., Asahi Kasei Medical Co., Ltd., and B. Braun Melsungen AG, among others.
The global acute kidney injury treatment market attained a value of USD 41.65 billion in 2022, driven by the rising incidences of acute kidney injury among the growing geriatric population. Aided by the increased investment in the research and development activities, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 6.20%. The market is projected to reach USD 59.78 billion by 2028.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on types, the industry can be segmented into prerenal, intrinsic renal, and postrenal acute kidney injury, among others. On the basis of treatment, the market is bifurcated into dialysis and supportive care. By end use, the industry is divided into hospitals and ambulatory surgical centres, among others. The major regional markets for acute kidney injury treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest market share. The key players in the above market include Angion, AM-Pharma B.V., Baxter International, Inc., Fresenius Medical Care Holdings, Inc., Asahi Kasei Medical Co., Ltd., and B. Braun Melsungen AG, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.